- Advanced search
- Immuno Portal
- Malaria Portal
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|International Nonproprietary Names|
|BIIB-033 | BIIB033|
|Opicinumab is a monoclonal antibody which acts as a functional antagonist of the neural protein, LINGO1 [1-2]. Opicinumab is being investigated for its clinical utility in diseases with underlying immune-driven demyelination.
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record. A BLAST search of patented peptide sequences reveals a 100% match between the variable heavy chain region of opicinumab and SEQ ID NO: 5 from patent US8058406 B2, and another identical match between the variable light chain of the antibody and the patent's SEQ ID NO: 13 .
|GtoPdb PubChem SID||310264704|
|Search PubMed clinical trials||opicinumab|
|Search PubMed titles||opicinumab|
|Search PubMed titles/abstracts||opicinumab|